慢性心力衰竭应用卡维地洛联合缬沙坦治疗的效果初步评定.docxVIP

慢性心力衰竭应用卡维地洛联合缠沙坦治疗的效果初步评 湖南省平江县第一人民医院湖南岳阳414500 【摘 要】目的：研究慢性心力衰竭应用卡维地洛联合绻沙坦治疗的效果。方法： 此次研究纳入的对象來源于2014年3月?2015年3月我院收治慢性心力衰竭患 者屮随机抽取的83例。将上述83例慢性心力衰竭患者随机分为X组41例和X+K 组42例。X组以绷沙坦进行治疗,X+K组应用卡维地洛联合绷沙坦治疗。比较(1) 慢性心力衰竭干预效果；(2)用药中出现的不良反应；(3)干预前和干预后患者 反映心功能的指标的差异。结果：(X+K组较ZX组慢性心力衰竭干预效果更 高，P0.05； (2)X+K组和X组用药过程均未出现明显不良反应，P0.05； (3) 干预前两组反映心功能的指标相似，P0.05；干预后X+K组较Z X组反映心功 能的指标改善更显著，P0.05。结论：慢性心力衰竭应用卡维地洛联合绷沙坦 治疗的效果确切，可有效改善患者心功能，无明显副作用，安全可靠，值得推广。 【关键词】慢性心力衰竭；卡维地洛；绷沙坦；效果 [Abstract] Objective： To study the effect of carvedilol combined with valsartan in the treatme nt of chr onic heart failure effect.Methods： the study in eluded 83 patie nts with chronic heart failure in our hospital from March March 2014 to 2009.The above 83 cases of chronic heart failure were randomly divided into X group of 41 cases and X+K group of 42 cases.X group were treated with valsartan, carvedilol and Valsartan in the treatment group X+K.To compare the effect of chronic heart failure (1)； (2) the adverse reacti ons in the treatme nt； (3) the differe nces of the in dexes of cardiac function before and after the intervention.Results： (1)X+K group than in the X Group in the effect of intervention in chronic heart failure more high, P lt; 0.05； (2) X+K group and the group x treatment process did not appear sigrHficantly adverse reactions, P gt; 0.05； (3) intervention before the two groups reflect the heart function index of similarityC P gt; 0.05)； after the intervention than x group of group X+K reflect cardiac function indexes improved more significantly, P lt; 0.05.Conclusion： the effect of chronic heart failure carvedilol combined with valsartan in the treatment is effective, can effectively improve the heart function of patients, and no obvious side effects, safe and reliable, worthy of promotion. [Key words] chronic heart failure； Carvedilol； valsartan； effect 心力衰竭是心血管内科常见多发疾病，是各种心脏病发病严重阶段。 其中，慢性心力衰竭是因心脏结构或者功能性疾病引发心脏射血功能损害或心室 无法有效充盈而岀现的综合征，其预后跟心脏病性质、诱发因素相关，需早期给 予治疗，积极控制原发病，去除诱因[1]。本研究对慢性心力衰竭应用卡维地洛 联合绷沙